Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department

Critical Care Medicine

Volumn 38, Issue 2, 2010, Pages 457-463

  De Kruif, Martijn D ^a,b   Limper, Maarten ^a,b   Gerritsen, Herman ^a   Spek, C Arnold ^b   Brandjes, Dees P M ^a   Ten Cate, Hugo ^c   Bossuyt, Patrick M ^b   Reitsma, Pieter H ^d   Van Gorp, Eric C M ^a  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Biological marker; Infection; Logistic regression; Procalcitonin; Prognosis; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROCALCITONIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CHILL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FEVER; HOSPITAL ADMISSION; HUMAN; INFECTION; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT DURATION;

EID: 74949084200     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181b9ec33     Document Type: Article

References (37)

1. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874
2. Vincent JL: Dear SIRS, I'm sorry to say that I don't like you. Crit Care Med 1997; 25: 372-374
3. Bossink AW, Groeneveld AB, Thijs LG: Prediction of microbial infection and mortality in medical patients with fever: Plasma procalcito-nin, neutrophilic elastase-alpha1-antitrypsin, and lactoferrin compared with clinical variables. Clin Infect Dis 1999; 29:398-407
4. Assicot M, Gendrel D, Carsin H, et al: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341:515-518
5. Mü ller B, Becker KL, Schächinger H, et al: Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 2000; 28:977-983
6. Simon L, Gauvin F, Amre DK, et al: Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: A systematic review and meta-analysis. Clin Infect Dis 2004; 39:206-217
7. Jones AE, Fiechtl JF, Brown MD, et al: Pro-calcitonin test in the diagnosis of bactere-mia: A meta-analysis. Ann Emerg Med 2007; 50:34-41
8. Uzzan B, Cohen R, Nicolas P, et al: Procalci-tonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: A systematic review and meta-analysis. Crit Care Med 2006; 34:1996-2003
9. Shafiq N, Malhotra S, Bhasin DK, et al: Estimating the diagnostic accuracy of procalci-tonin as a marker of the severity of acute pancreatitis: A meta-analytic approach. JOP 2005; 6:231-237
10. Oostenbrink R, Moons KG, Bleeker SE, et al: Diagnostic research on routine care data: Prospects and problems. J Clin Epidemiol 2003; 56:501-506
11. Morgenthaler NG, Struck J, Fischer-Schulz C, et al: Sensitive immunoluminometric assay for the detection of procalcitonin. Clin Chem 2002; 48:788-790
12. Bates DW, Cook EF, Goldman L, et al: Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med 1990; 113:495-500
13. Bates DW, Sands K, Miller E, Lanken PN, et al: Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 1997; 176:1538-1551
14. Aalto H, Takala A, Kautiainen H, et al: Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur J Clin Microbiol Infect Dis 2004; 23:699-704
15. Hopstaken RM, Muris JW, Knottnerus JA, et al: Contributions of symptoms, signs, eryth-rocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003; 53:358-364
16. Isaacman DJ, Shults J, Gross TK, et al: Predictors of bacteremia in febrile children 3 to 36 months of age. Pediatrics 2000; 106:977-982
17. Jaimes F, Arango C, Ruiz G, et al: Predicting bacteremia at the bedside. Clin Infect Dis 2004; 38:357-362
18. Metersky ML, Ma A, Bratzler DW, et al: Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004; 169:342-347
19. Mozes B, Milatiner D, Block C, et al: Inconsistency of a model aimed at predicting bac-teremia in hospitalized patients. J Clin Epidemiol 1993; 46:1035-1040
20. Pantell RH, Newman TB, Bernzweig J, et al: Management and outcomes of care of fever in early infancy. JAMA 2004; 291:1203-1212
21. Persson L, Engervall P, Magnuson A, et al: Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand J Infect Dis 2004; 36: 365-371
22. Kolata G: The art of learning from experience: Statistician Bradley Efron tells what his field is about and how a new method, the bootstrap, exploits the power of large-scale computing. Science 1984; 225:156-158
23. Hausfater P, Juillien G, Madonna-Py B, et al: Serum procalcitonin measurement as diagnostic and prognostic marker in febrile adult patients presenting to the emergency department. Crit Care 2007; 11:R60
24. Dubos F, Moulin F, Raymond J, et al: [Distinction between bacterial and aseptic meningitis in children: Refinement of a clinical decision rule]. Arch Pediatr 2007; 14: 434-438
25. Peters RP, Twisk JW, van Agtmael MA, et al: The role of procalcitonin in a decision tree for prediction of bloodstream infection in febrile patients. Clin Microbiol Infect 2006; 12:1207-1213
26. Ugarte H, Silva E, Mercan D, et al: Procalci-tonin used as a marker of infection in the intensive care unit. Crit Care Med 1999; 27: 498-504
27. Viallon A, Zeni F, Lambert C, et al: High sensitivity and specificity of serum procalci-tonin levels in adults with bacterial meningitis. Clin Infect Dis 1999; 28:1313-1316
28. Huang DT, Weissfeld LA, Kellum JA, et al: Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia. Ann Emerg Med 2008; 52:48-58.e2
29. Lee CC, Chen SY, Tsai CL, et al: Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-Reactive protein in patients with sepsis at the Emergency Department. Shock 2008; 29:322-327
30. Perrin FM, Lipman MC, McHugh TD, et al: Biomarkers of treatment response in clinical trials of novel antituberculosis agents. Lancet Infect Dis 2007; 7:481-490
31. Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al: Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial. Lancet 2004; 363:600-607
32. Christ-Crain M, Stolz D, Bingisser R, et al: Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: A randomized trial. Am J Respir Crit Care Med 2006; 174:84-93
33. Stolz D, Christ-Crain M, Bingisser R, et al: Antibiotic treatment of exacerbations of COPD: A randomized, controlled trial comparing procalcitonin-guidance with standard therapy. Chest 2007; 131:9-19
34. Schuetz P, Christ-Crain M, Wolbers M, et al: Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: A prospective, multi-center, randomized controlled trial. BMC Health Serv Res 2007; 7:102
35. Nobre V, Harbarth S, Graf JD, et al: Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 2008; 177: 498-505
36. Peipert JF, MG Phipps: Observational studies. Clin Obstet Gynecol 1998; 41:235-244
37. Vandenbroucke JP, von Elm E, Altman DG, et al: Strengthening the reporting of observational studies in epidemiology (STROBE): Explanation and elaboration. PLoS Med 2007; 4:e297